Determinants of brain iron in multiple sclerosis: A quantitative 3T MRI study

Neurology

Volumn 77, Issue 18, 2011, Pages 1691-1697

  Khalil, M ^a,c   Langkammer, C ^a   Ropele, S ^a   Petrovic, K ^a   Wallner Blazek, M ^a   Loitfelder, M ^a,b   Jehna, M ^a,b   Bachmaier, G ^a   Schmidt, R ^a   Enzinger, C ^a   Fuchs, S ^a   Fazekas, F ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN LEVEL; CONTROLLED STUDY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 82955175677     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318236ef0e     Document Type: Article

References (38)

1. Kell DB. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch Toxicol 2010;84:825-889.
2. Campbell A, Smith M.A., Sayre LM, Bondy SC, Perry G. Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 2001;55:125-132. (Pubitemid 32722152)
3. Gutteridge JM. Iron and oxygen radicals in brain. Ann Neurol 1992;32(suppl):S16-S21.
4. Hallgren B, Sourander P. The effect of age on the nonhaemin iron in the human brain. J Neurochem 1958;3: 41-51.
5. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: Imaging and neurotherapeutic implications. Neurotherapeutics 2007;4: 371-386. (Pubitemid 46962416)
6. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863-873. (Pubitemid 39482155)
7. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987;149:357-363. (Pubitemid 17104997)
8. Grimaud J, Millar J, Thorpe JW, Moseley IF, McDonald WI, Miller DH. Signal intensity on MRI of basal ganglia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 59:306-308.
9. Khalil M, Enzinger C, Langkammer C, et al. Quantitative assessment of brain iron by R(2) relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009;15:1048-1054.
10. Burgetova A, Seidl Z, Krasensky J, Horakova D, Vaneckova M. Multiple sclerosis and the accumulation of iron in the basal ganglia: quantitative assessment of brain iron using MRI t(2) relaxometry. Eur Neurol 2010;63:136-143.
11. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62-68. (Pubitemid 34052557)
12. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 tesla with sensitivity to iron. Ann Neurol 2008;64:707-713.
13. Ge Y, Jensen JH, Lu H, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28:1639-1644. (Pubitemid 47598131)
14. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010;257:455-462.
15. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157-1174.
16. Polman C.H., Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria." Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452. (Pubitemid 14237132)
18. Rao S. A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee: Medical College of Wisconsin; 1990.
19. Khalil M, Enzinger C, Langkammer C, et al. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 2011;17:173-180.
20. Scherer P, Baum K, Bauer H, Gohler H, Miltenburger C. Normalization of the brief repeatable battery of neuropsychological tests (BRB-N) for german-speaking regions: application in relapsing-remitting and secondary progressive multiple sclerosis patients. Nervenarzt 2004;75:984-990. (Pubitemid 39468510)
21. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2*measurements in ironoverloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med 2008; 60:1082-1089.
22. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-922.
23. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208-S219. (Pubitemid 39421720)
24. Enzinger C, Ropele S, Smith S, et al. Accelerated evolution of brain atrophy and "black holes" in MS patients with A.P.OE-epsilon 4. Ann Neurol 2004;55:563-569. (Pubitemid 38391974)
25. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening ('black T2-) in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000;11:15-21. (Pubitemid 30053382)
26. Ceccarelli A, Rocca M.A., Neema M, et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult Scler 2010;16:39-44.
27. Ropele S, de Graaf W, Khalil M, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011;34:13-21
28. Zivadinov R, Schirda C, Dwyer MG, et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol 2010;29: 158-175.
29. Tjoa CW, Benedict RH, Weinstock-Guttman B, Fabiano AJ, Bakshi R. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005;234:17-24. (Pubitemid 40910338)
30. Zhang Y, Metz LM, Yong VW, Mitchell JR. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study. J Neurol Sci 2010;297:76-81.
31. Brass SD, Benedict RH, Weinstock-Guttman B, Munschauer F, Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006; 12:437-444. (Pubitemid 44132584)
32. Bermel RA, Puli SR, Rudick RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62:1371-1376. (Pubitemid 41352053)
33. Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001; 185:19-26. (Pubitemid 32215497)
34. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285. (Pubitemid 28065253)
35. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397-399.
36. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997;760:298-303. (Pubitemid 27304170)
37. Petzold A, Eikelenboom MJ, Gveric D, et al. Markers for different glial cell responses in multiple sclerosis: Clinical and pathological correlations. Brain 2002;125:1462-1473. (Pubitemid 34755162)
38. Mehindate K, Sahlas DJ, Frankel D, et al. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: Implications for multiple sclerosis. J Neurochem 2001;77:1386-1395. (Pubitemid 32523691)